Literature DB >> 18031566

The mast cell and allergic diseases: role in pathogenesis and implications for therapy.

J M Brown1, T M Wilson, D D Metcalfe.   

Abstract

Mast cells have long been recognized for their role in the genesis of allergic inflammation; and more recently for their participation in innate and acquired immune responses. Mast cells reside within tissues including the skin and mucosal membranes, which interface with the external environment; as well as being found within vascularized tissues next to nerves, blood vessels and glandular structures. Mast cells have the capability of reacting both within minutes and over hours to specific stimuli, with local and systemic effects. Mast cells express the high affinity IgE receptor (FcepsilonRI) and upon aggregation of FcepsilonRI by allergen-specific IgE, mast cells release and generate biologically active preformed and newly synthesized mediators which are involved in many aspects of allergic inflammation. While mast cells have been well documented to be essential for acute allergic reactions, more recently the importance of mast cells in reacting through pattern recognition receptors in innate immune responses has become recognized. Moreover, as our molecular understanding of the mast cell has evolved, novel targets for modulation have been identified with promising therapeutic potential.

Entities:  

Mesh:

Year:  2007        PMID: 18031566     DOI: 10.1111/j.1365-2222.2007.02886.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  93 in total

1.  Providing the TORC for cell cycle progression in neoplastic mast cells.

Authors:  Daniel Smrž; Todd M Wilson; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

2.  Mast cell activation syndrome: Proposed diagnostic criteria.

Authors:  Cem Akin; Peter Valent; Dean D Metcalfe
Journal:  J Allergy Clin Immunol       Date:  2010-10-28       Impact factor: 10.793

Review 3.  Mast cells and mastocytosis.

Authors:  Dean D Metcalfe
Journal:  Blood       Date:  2008-08-15       Impact factor: 22.113

4.  Mast cells contribute to altered vascular reactivity and ischemia-reperfusion injury following cerium oxide nanoparticle instillation.

Authors:  Christopher J Wingard; Dianne M Walters; Brook L Cathey; Susana C Hilderbrand; Pranita Katwa; Sijie Lin; Pu Chun Ke; Ramakrishna Podila; Apparao Rao; Robert M Lust; Jared M Brown
Journal:  Nanotoxicology       Date:  2010-11-03       Impact factor: 5.913

Review 5.  Understanding the mechanisms of anaphylaxis.

Authors:  Richard D Peavy; Dean D Metcalfe
Journal:  Curr Opin Allergy Clin Immunol       Date:  2008-08

6.  Innate Immune Responses to Nanoparticle Exposure in the Lung.

Authors:  Elizabeth A Thompson; Brian C Sayers; Ellen E Glista-Baker; Kelly A Shipkowski; Alexia J Taylor; James C Bonner
Journal:  J Environ Immunol Toxicol       Date:  2014 Jul-Sep

Review 7.  From immunotoxicity to nanotherapy: the effects of nanomaterials on the immune system.

Authors:  Matthew J Smith; Jared M Brown; William C Zamboni; Nigel J Walker
Journal:  Toxicol Sci       Date:  2014-01-15       Impact factor: 4.849

Review 8.  Immunotoxicological impact of engineered nanomaterial exposure: mechanisms of immune cell modulation.

Authors:  Xiaojia Wang; Shaun P Reece; Jared M Brown
Journal:  Toxicol Mech Methods       Date:  2013-01-17       Impact factor: 2.987

Review 9.  Adapters in the organization of mast cell signaling.

Authors:  Damiana Alvarez-Errico; Eva Lessmann; Juan Rivera
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

Review 10.  Current immunological and molecular biological perspectives on seafood allergy: a comprehensive review.

Authors:  Nicki Y H Leung; Christine Y Y Wai; ShangAn Shu; Jinjun Wang; Thomas P Kenny; Ka Hou Chu; Patrick S C Leung
Journal:  Clin Rev Allergy Immunol       Date:  2014-06       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.